Trial intelligence / Profile preview

Esketamine for Postoperative Pruritus in Intrahepatic Cholestasis of Pregnancy

NCT07560722Not yet recruiting

Sponsor
Tianjin Medical University General Hospital
Start
May 2026
Primary completion
May 2027
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in intrahepatic cholestasis of pregnancy (ICP) comparing Placebo group with Esketamine group (2 arms). Primary endpoint: Numeric Rating Scale pruritus score at 24 hours. Planned start May 2026; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

intrahepatic cholestasis of pregnancy (ICP)

Beyond the preview

Go deeper on NCT07560722.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07560722.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call